Revised Geneva Score Calculator

Calculate the Revised Geneva Score for suspected pulmonary embolism using standardized weighted criteria for low, intermediate, and high clinical probability assessment.

Last updated on: April 1, 2026

Calculate Revised Geneva Score

Select yes if age is greater than 65 years.
Select yes if there is a previous history of DVT or pulmonary embolism.
Select yes if there was surgery or lower limb fracture within the past month.
Select yes if active malignancy is present.
Select yes if unilateral lower limb pain is present.
Select yes if hemoptysis is present.
Choose the heart rate range that applies.
Select yes if pain on deep venous palpation of the lower limb and unilateral edema are present.

What the Revised Geneva Score Measures

The Revised Geneva Score is a fully standardized clinical prediction rule used to estimate pretest probability of pulmonary embolism in patients with suspected PE.

Unlike clinical gestalt-based tools, it uses only predefined weighted criteria, making it useful for structured and reproducible PE probability assessment.

Probability Categories

Low Clinical Probability: Score 0–3. This corresponds to a low pretest probability group and is often paired with D-dimer-based rule-out strategies in the appropriate setting.
Intermediate Clinical Probability: Score 4–10. This corresponds to an intermediate pretest probability group and usually requires structured diagnostic follow-up depending on D-dimer and clinical context.
High Clinical Probability: Score 11 or more. This corresponds to a high pretest probability group and usually supports prompt diagnostic imaging or advanced evaluation.

Guideline Context

The Revised Geneva Score is one of the most commonly used standardized tools for pretest probability assessment in suspected pulmonary embolism.

It is typically integrated into pathways that combine clinical probability with D-dimer testing and imaging rather than being used in isolation.

Practical Workflow

Low or intermediate probability may support D-dimer-based rule-out strategies depending on the diagnostic pathway in use.

High probability generally supports more direct progression toward definitive imaging and urgent clinical evaluation.

This page has been medically reviewed by Dr. Khoulah Attia – PharmD, Immunology Specialist.

Related Calculators

PESI Score Calculator
4PEPS Score Calculator
Diabetes Remission Score Calculator
Anion Gap Calculator (mmol/L)
LDL/HDL Ratio Calculator
Light's Criteria Calculator